Prime Medicine PRME Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$198.37M+1.4% | -$201.14M-1.9% | -$197.34M+1.0% | -$199.28M+1.4% | -$202.01M-3.1% | ||
| $7.48M+2.1% | $7.32M+2.2% | $7.16M+4.7% | $6.84M+5.0% | $6.51M+6.3% | ||
| $28.23M-3.5% | $29.27M-4.6% | $30.69M+23.9% | $24.77M-6.7% | $26.54M+1.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$6.56M-44.2% | -$4.55M-202% | $4.44M-65.0% | $12.69M-10.2% | $14.13M-12.4% | ||
| -$3.78M+13.4% | -$4.36M-20.8% | -$3.61M-105% | $69.49M-1.4% | $70.48M-2.0% | ||
| $1.49M+244% | $432K— | —— | —— | —— | ||
| $10.13M+4.4% | $9.7M+4.2% | $9.3M+1.1% | $9.2M-19.4% | $11.42M-7.6% | ||
| -$6.64M-23.8% | -$5.36M-30.5% | -$4.11M-44.5% | -$2.84M+21.9% | -$3.64M+43.7% | ||
| -$156.42M+3.8% | -$162.56M— | —— | —— | —— | ||
| $2.32M-48.7% | $4.53M-24.9% | $6.03M-14.6% | $7.06M-4.5% | $7.39M+1.3% | ||
| $164.38M-20.0% | $205.41M— | —— | —— | —— | ||
| —— | —— | -$114.62M-19.7% | -$95.75M-37.8% | -$69.5M— | ||
| —— | —— | —— | —— | $57.75M-15.6% | ||
| $393K— | $0— | —— | —— | —— | ||
| $145.91M-3.7% | $151.51M+0.4% | $150.95M+238% | $44.71M+0.4% | $44.55M-77.3% | ||
| —— | —— | —— | -$1.6M— | —— | ||
| $2.2M+13.8% | $1.94M+49.7% | $1.29M-18.6% | $1.59M-38.4% | $2.58M-16.5% | ||
| —— | —— | —— | —— | —— | ||
| -$6.64M-23.8% | -$5.36M-30.5% | -$4.11M-44.5% | -$2.84M+21.9% | -$3.64M+43.7% | ||
| -$6.56M-44.2% | -$4.55M-202% | $4.44M-65.0% | $12.69M-10.2% | $14.13M-12.4% | ||
| $10.13M+4.4% | $9.7M+4.2% | $9.3M+1.1% | $9.2M-19.4% | $11.42M-7.6% | ||
| —— | $0+100% | -$250K+50.0% | -$500K+33.3% | -$750K+25.0% | ||
| $164.38M-20.0% | $205.41M— | —— | —— | —— | ||
| $143.67M+50.0% | $95.78M+6.9% | $89.58M-17.4% | $108.45M-19.5% | $134.7M-34.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$3.78M+13.4% | -$4.36M-20.8% | -$3.61M-105% | $69.49M-1.4% | $70.48M-2.0% | ||
| -$6.64M-23.8% | -$5.36M-30.5% | -$4.11M-44.5% | -$2.84M+21.9% | -$3.64M+43.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $3.12M— | ||
| —— | $10.91M+33.3% | $8.18M+50.0% | $5.46M+100% | $2.73M— | ||
| -$158.74M+5.0% | -$167.1M— | —— | —— | —— | ||
| -$158.74M+5.0% | -$167.1M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
